ArticleBMJ open2025

Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study.

Ana Lilia Serna-Valverde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.